新药临床试验期间药物警戒和风险控制研究五:我国药物警戒和风险控制监管体系调研与结果分析
杨建红, 左晓春, 智会静, 冯红云, 李浩, 周凌芸, 詹骁靖, 吕心欢, 陈江鹏, 张象麟
Research V on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: A Questionnaire Survey and Result Analysis on Regulatory System of Pharmacovigilance and Risk Control in China
Yang Jianhong, Zuo Xiaochun, Zhi Huijing, Feng Hongyun, Li Hao, Zhou Lingyun, Zhan Xiaojing, Lü Xinhuan, Chen Jiangpeng, Zhang Xianglin
中国药事
.
2022, (6): 644
-658
.
DOI: 10.16153/j.1002-7777.2022.06.007
